malondialdehyde has been researched along with Bowel Diseases, Inflammatory in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (3.85) | 18.2507 |
2000's | 5 (19.23) | 29.6817 |
2010's | 16 (61.54) | 24.3611 |
2020's | 4 (15.38) | 2.80 |
Authors | Studies |
---|---|
Ahmad, R; Dhawan, P; Duryee, MJ; Eichele, DD; Hunter, CD; Mitra, A; Rosen, MJ; Singh, AB; Singh, S; Smith, LM; Talmon, GA; Thiele, GM | 1 |
Adeghate, E; Amir, N; Bastaki, SMA; Ojha, S | 1 |
Chen, S; Hu, S; Li, W; Liu, Q; Ma, X; Tang, J; Wei, P; Zeng, J; Zhao, M | 1 |
Angelucci, F; Antonioli, L; Benvenuti, L; Bertani, L; Blandizzi, C; Colucci, R; Coviello, V; D'Antongiovanni, V; Di Salvo, C; Fornai, M; Giusti, L; Ha, QTK; Haskó, G; La Motta, C; Németh, ZH; Oh, WK; Pellegrini, C; Quattrini, L; Ronci, M; Semeghini, G; Zallocco, L | 1 |
Merwid-Ląd, A; Szandruk, M; Szeląg, A | 1 |
Dudzińska, E; Gil-Kulik, P; Gryzinska, M; Kocki, J; Ognik, K | 1 |
Liu, X; Xu, X; Yu, X; Zhang, X | 1 |
Cavallini, DCU; Celiberto, LS; Pinto, RA; Rossi, EA; Vallance, BA | 1 |
Byrav D S, P; Chakrabarti, A; Khanduja, KL; Medhi, B; Prakash, A; Vaiphei, K | 1 |
Datta, S; De, AK; Mukherjee, A; Sana, S | 1 |
Barbosa, JS; Brito, GA; Correia, ES; Fernandes, GC; Goes, AC; Guimaraes, SB; Lima Júnior, RC; Pinto, FM; Ribeiro, RA; Rodrigues, LV | 1 |
Smith, D; Španěl, P | 1 |
Geng, Y; Lu, Z; Qin, M; Shi, JS; Xu, H; Xu, X; Xu, ZH | 1 |
Agrogiannis, G; Burris, DL; Butt, Z; DeLucca, JF; Dhoble, SJ; Douvi, G; Elliott, DM; Geiger, R; Gikas, A; Hollinger, KR; Hottor, HT; Jiang, W; Li, X; Little, SJ; Marohn, M; McCaskill, ML; Mehta, SR; Moore, AC; Papalois, A; Patel, RV; Pathak, MS; Patsouris, E; Rai, VK; Rais, R; Rathaiah, M; Rojas, C; Sapkota, M; Singh, N; Singh, PK; Singh, V; Slusher, BS; Smith, DM; Stathis, M; Syrmos, N; Thomas, AG; Triantafillidis, J; Vagianos, C; Venkatramu, V; Vornov, JJ; Wozniak, KM; Wyatt, TA; Zhai, H | 1 |
Medhi, B; Pandhi, P; Prakash, O; Saikia, UN | 1 |
Hasan, F; Khan, I; Siddique, I | 1 |
Byrav, DS; Chakrabarti, A; Khanduja, KL; Medhi, B; Vaiphei, K | 1 |
Alican, I; Aydin, MS; Ercan, F; Karakoyun, B; Ogunc, AV; Uslu, U; Yuksel, M | 1 |
Akarsu, M; Akman, T; Akpinar, H; Resmi, H; Sezer, E; Taylan, E | 1 |
Gaikwad, PS; Otari, KV; Shete, RV; Upasani, CD | 1 |
Aygun, C; Bahcecioglu, IH; Demirel, U; Orhan, C; Ozercan, IH; Sahin, K; Tuzcu, M; Yalniz, M | 1 |
Achitei, D; Balan, G; Ciobica, A; Gologan, E; Stanciu, C; Stefanescu, G | 1 |
Bartsch, H; Nair, J | 1 |
Berge, RK; Berstad, A; Erichsen, K; Grimstad, T; Hausken, T; Ulvik, RJ | 1 |
Belogi, L; Cavallo, G; Croce, C; Guida, G; Modesti, A; Santiangeli, C; Tubaro, E | 1 |
Britti, D; Caputi, AP; Centorrino, T; Ciccolo, A; Cuzzocrea, S; Mazzon, E; McDonald, MC; Mota-Filipe, H; Terranova, ML; Thiemermann, C | 1 |
1 review(s) available for malondialdehyde and Bowel Diseases, Inflammatory
Article | Year |
---|---|
Preclinical evidence for quercetin against inflammatory bowel disease: a meta-analysis and systematic review.
Topics: Animals; Antioxidants; Glutathione; Inflammatory Bowel Diseases; Malondialdehyde; Nitric Oxide; Oxidative Stress; Quercetin | 2022 |
1 trial(s) available for malondialdehyde and Bowel Diseases, Inflammatory
Article | Year |
---|---|
Effects of ferrous sulphate and non-ionic iron-polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease.
Topics: Adolescent; Adult; Aged; Antioxidants; Biomarkers; Dinoprost; Female; Ferric Compounds; Ferrous Compounds; Hematinics; Humans; Inflammatory Bowel Diseases; Iron Deficiencies; Male; Malondialdehyde; Middle Aged; Oxidation-Reduction; Oxidative Stress; Prospective Studies; Reactive Oxygen Species; Tablets; Vasoconstrictor Agents | 2005 |
24 other study(ies) available for malondialdehyde and Bowel Diseases, Inflammatory
Article | Year |
---|---|
Identification of Immunoglobulin G Autoantibody Against Malondialdehyde-Acetaldehyde Adducts as a Novel Serological Biomarker for Ulcerative Colitis.
Topics: Acetaldehyde; Adult; Autoantibodies; Biomarkers; Child; Colitis, Ulcerative; Crohn Disease; Humans; Immunoglobulin G; Inflammatory Bowel Diseases; Malondialdehyde | 2022 |
Lycopodium Mitigates Oxidative Stress and Inflammation in the Colonic Mucosa of Acetic Acid-Induced Colitis in Rats.
Topics: Acetic Acid; Animals; Anti-Inflammatory Agents; Antioxidants; Body Weight; Colitis; Colitis, Ulcerative; Cytokines; Glutathione; Inflammation; Inflammatory Bowel Diseases; Intestinal Mucosa; Leukocyte L1 Antigen Complex; Lycopodium; Malondialdehyde; Oxidative Stress; Peroxidase; Rats; Rats, Wistar | 2022 |
Preclinical Development of FA5, a Novel AMP-Activated Protein Kinase (AMPK) Activator as an Innovative Drug for the Management of Bowel Inflammation.
Topics: AMP-Activated Protein Kinases; Animals; Benzofurans; Body Weight; Cell Line; Colon; Dinitrofluorobenzene; Drug Development; Electrophoresis, Gel, Two-Dimensional; Enzyme Activators; Gene Ontology; Inflammatory Bowel Diseases; Interleukin-10; Male; Malondialdehyde; Mice; Organ Size; Phosphorylation; Rats, Sprague-Dawley; Spleen; Tumor Necrosis Factor-alpha | 2021 |
The impact of mangiferin from Belamcanda chinensis on experimental colitis in rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Colitis; Cytokines; Disease Models, Animal; Inflammation Mediators; Inflammatory Bowel Diseases; Iridaceae; Male; Malondialdehyde; Oxidative Stress; Plant Extracts; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha; Xanthones | 2018 |
Oxidative Stress and Effect of Treatment on the Oxidation Product Decomposition Processes in IBD.
Topics: Adult; Aged; Antioxidants; Female; Humans; Inflammatory Bowel Diseases; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species | 2018 |
The protective effects of Poria cocos-derived polysaccharide CMP33 against IBD in mice and its molecular mechanism.
Topics: Animals; Chromatography, High Pressure Liquid; Colon; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Fatty Acid-Binding Proteins; Haptoglobins; Hydroxymethylglutaryl-CoA Synthase; Inflammatory Bowel Diseases; Male; Malondialdehyde; Metabolomics; Mice; N-Acetylgalactosaminyltransferases; Peroxidase; Polysaccharides; Proteomics; Sulfasalazine; Tandem Mass Spectrometry; Trinitrobenzenesulfonic Acid; Wolfiporia | 2018 |
Isolation and Characterization of Potentially Probiotic Bacterial Strains from Mice: Proof of Concept for Personalized Probiotics.
Topics: Animals; Bifidobacterium; Biomarkers; Colitis; Colon; Cytokines; Dextran Sulfate; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Gastrointestinal Microbiome; Inflammation; Inflammatory Bowel Diseases; Intestines; Lactobacillus; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Peroxidase; Probiotics | 2018 |
Comparative evaluation of different doses of PPAR-γ agonist alone and in combination with sulfasalazine in experimentally induced inflammatory bowel disease in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Malondialdehyde; Peroxidase; Pioglitazone; PPAR gamma; Rats; Sulfasalazine; Thiazolidinediones; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2013 |
Protective efficacy of ursodeoxycholic acid nanoparticles in animal model of inflammatory bowel disease.
Topics: Animals; Cholagogues and Choleretics; Colon; Drug Carriers; Inflammatory Bowel Diseases; Male; Malondialdehyde; Nanoparticles; Nitric Oxide; Particle Size; Peroxidase; Rats; Rats, Wistar; Ursodeoxycholic Acid | 2014 |
Electroacupuncture ameliorates experimental colitis induced by TNBS through activation of interleukin-10 and inhibition of iNOS in mice.
Topics: Acupuncture Points; Animals; Anti-Inflammatory Agents; Colitis; Colon; Disease Models, Animal; Electroacupuncture; Immunohistochemistry; Inflammatory Bowel Diseases; Interleukin-10; Interleukin-1beta; Male; Malondialdehyde; Mice; Nitric Oxide Synthase Type II; Peroxidase; Random Allocation; Trinitrobenzenesulfonic Acid | 2014 |
Status of selected ion flow tube MS: accomplishments and challenges in breath analysis and other areas.
Topics: Acetonitriles; Biomarkers; Breath Tests; Colorectal Neoplasms; Equipment Design; Feces; Humans; Inflammatory Bowel Diseases; Malondialdehyde; Mass Spectrometry; Volatile Organic Compounds | 2016 |
Anti-Inflammatory Effects of Ethanol Extract of Lion's Mane Medicinal Mushroom, Hericium erinaceus (Agaricomycetes), in Mice with Ulcerative Colitis.
Topics: Animals; Anti-Inflammatory Agents; Basidiomycota; Colitis, Ulcerative; Colon; Complex Mixtures; Disease Models, Animal; Humans; Inflammation; Inflammatory Bowel Diseases; Interleukin-1beta; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Nitric Oxide; Oxidative Stress; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2016 |
Topics: Adalimumab; Anemia; Animals; Anti-Inflammatory Agents; Colon; Disease Models, Animal; Humans; Inflammatory Bowel Diseases; Infliximab; Intestinal Mucosa; Iron; Male; Malondialdehyde; Patient Outcome Assessment; Psychometrics; Rats; Rats, Wistar; Self Report; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2016 |
Effect of different doses of thalidomide in experimentally induced inflammatory bowel disease in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Disease Models, Animal; Female; Gastrointestinal Agents; Inflammatory Bowel Diseases; Male; Malondialdehyde; Peroxidase; Rats; Rats, Wistar; Sulfasalazine; Thalidomide; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2008 |
Suppression of Na+/H+ exchanger isoform-3 in human inflammatory bowel disease: lack of reversal by 5'-aminosalicylate treatment.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Blotting, Western; Case-Control Studies; Colitis, Ulcerative; Colon; Crohn Disease; Female; Humans; Inflammatory Bowel Diseases; Interleukin-1beta; Male; Malondialdehyde; Middle Aged; Peroxidase; Protein Isoforms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Salicylates; Sodium Chloride; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Sodium-Potassium-Exchanging ATPase; Tumor Necrosis Factor-alpha; Water | 2009 |
Comparative evaluation of different doses of green tea extract alone and in combination with sulfasalazine in experimentally induced inflammatory bowel disease in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Camellia sinensis; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Inflammatory Bowel Diseases; Lipid Peroxidation; Male; Malondialdehyde; Peroxidase; Plant Extracts; Rats; Rats, Wistar; Sulfasalazine; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2011 |
The effect of phosphodiesterase-5 inhibition by sildenafil citrate on inflammation and apoptosis in rat experimental colitis.
Topics: Animals; Apoptosis; Colitis; Female; Glutathione; Inflammatory Bowel Diseases; Interleukin-10; Male; Malondialdehyde; NG-Nitroarginine Methyl Ester; Peroxidase; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Sildenafil Citrate; Sulfones; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2011 |
Erythrocyte deformability and oxidative stress in inflammatory bowel disease.
Topics: Adult; Erythrocyte Deformability; Erythrocytes; Female; Humans; Inflammatory Bowel Diseases; Lipid Peroxidation; Male; Malondialdehyde; Oxidative Stress; Prospective Studies | 2012 |
Protective effect of aqueous extract of Spinacia oleracea leaves in experimental paradigms of inflammatory bowel disease.
Topics: Animals; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Disease Models, Animal; Dose-Response Relationship, Drug; Enterocolitis; Female; Inflammatory Bowel Diseases; Lipid Peroxidation; Male; Malondialdehyde; Mice; Plant Extracts; Plant Leaves; Protective Agents; Rats; Rats, Wistar; Spinacia oleracea | 2012 |
Nadroparin sodium activates Nrf2/HO-1 pathway in acetic acid-induced colitis in rats.
Topics: Acetic Acid; Animals; Colitis; Colon; Cyclooxygenase 2; Heme Oxygenase-1; Inflammatory Bowel Diseases; Interleukin-6; Male; Malondialdehyde; Nadroparin; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Random Allocation; Rats; Rats, Wistar; Reactive Oxygen Species; Transcription Factor AP-1; Tumor Necrosis Factor-alpha | 2012 |
Different profile of peripheral antioxidant enzymes and lipid peroxidation in active and non-active inflammatory bowel disease patients.
Topics: Adult; C-Reactive Protein; Case-Control Studies; Female; Glutathione Peroxidase; Humans; Inflammatory Bowel Diseases; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Prospective Studies; Superoxide Dismutase; Young Adult | 2013 |
Accumulation of lipid peroxidation-derived DNA lesions: potential lead markers for chemoprevention of inflammation-driven malignancies.
Topics: Aldehydes; Cross-Linking Reagents; DNA Adducts; DNA Damage; Ethanol; Humans; Inflammation; Inflammatory Bowel Diseases; Lipid Peroxidation; Liver; Malondialdehyde; Molecular Structure; Neoplasms; Oxidative Stress; Pancreatitis, Chronic; Risk Factors | 2005 |
Effect of a new de-N-acetyl-lysoglycosphingolipid on chemically-induced inflammatory bowel disease: possible mechanism of action.
Topics: Animals; Arachidonic Acid; Carbohydrate Sequence; Colitis; Colon; Gangliosides; Humans; Inflammatory Bowel Diseases; Leukotriene B4; Male; Malondialdehyde; Molecular Sequence Data; Organ Size; Pancreas; Peroxidase; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Spleen; Synovial Fluid; Trinitrobenzenesulfonic Acid | 1993 |
Calpain inhibitor I reduces colon injury caused by dinitrobenzene sulphonic acid in the rat.
Topics: Adenosine Diphosphate Ribose; Analysis of Variance; Animals; Cysteine Proteinase Inhibitors; Dinitrobenzenes; Glycoproteins; Inflammatory Bowel Diseases; Intercellular Adhesion Molecule-1; Male; Malondialdehyde; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; P-Selectin; Peroxidase; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Sulfonic Acids; Tyrosine; Up-Regulation | 2001 |